6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Resolution of Protein-Losing Enteropathy after Congenital Heart Disease Repair by Selective Lymphatic Embolization

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          With improving survival of children with complex congenital heart disease (CCHD), postoperative complications, like protein-losing enteropathy (PLE) are increasingly encountered. A 3-year-old girl with surgically corrected CCHD (ventricular inversion/L-transposition of the great arteries, ventricular septal defect, pulmonary atresia, post-double switch procedure [Rastelli and Glenn]) developed chylothoraces. She was treated with pleurodesis, thoracic duct ligation and subsequently developed chylous ascites and PLE (serum albumin ≤0.9 g/dL) and was malnourished, despite nutritional rehabilitation. Lymphangioscintigraphy/single-photon emission computed tomography showed lymphatic obstruction at the cisterna chyli level. A segmental chyle leak and chylous lymphangiectasia were confirmed by gastrointestinal endoscopy, magnetic resonance (MR) enterography, and MR lymphangiography. Selective glue embolization of leaking intestinal lymphatic trunks led to prompt reversal of PLE. Serum albumin level and weight gain markedly improved and have been maintained for over 3 years. Selective interventional embolization reversed this devastating lymphatic complication of surgically corrected CCHD.

          Related collections

          Most cited references12

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states

          Protein losing enteropathy (PLE) has been associated with more than 60 different conditions, including nearly all gastrointestinal diseases (Crohn’s disease, celiac, Whipple’s, intestinal infections, and so on) and a large number of non-gut conditions (cardiac and liver disease, lupus, sarcoidosis, and so on). This review presents the first attempt to quantitatively understand the magnitude of the PLE in relation to the associated pathology for three different disease categories: 1) increased lymphatic pressure (e.g., lymphangiectasis); 2) diseases with mucosal erosions (e.g., Crohn’s disease); and 3) diseases without mucosal erosions (e.g., celiac disease). The PLE with lymphangiectasis results from rupture of the mucosal lymphatics, with retrograde drainage of systemic lymph into the intestinal lumen with the resultant loss of CD4 T cells, which is diagnostic. Mucosal erosion PLE results from macroscopic breakdown of the mucosal barrier, with the epithelial capillaries becoming the rate-limiting factor in albumin loss. The equation derived to describe the relationship between the reduction in serum albumin (CP) and PLE indicates that gastrointestinal albumin clearance must increase by at least 17 times normal to reduce the CP by half. The strengths and limitations of the two quantitative measures of PLE (51Cr-albumin or α1-antitrypsin [αAT] clearance) are reviewed. αAT provides a simple quantitative diagnostic test that is probably underused clinically. The strong, unexplained correlation between minor decreases in CP and subsequent mortality in seemingly healthy individuals raises the question of whether subclinical PLE could account for the decreased CP and, if so, could the mechanism responsible for PLE play a role in the increased mortality? A large-scale study correlating αAT clearance with serum albumin concentrations will be required in order to determine the role of PLE in the regulation of the serum albumin concentration of seemingly healthy subjects.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Transhepatic lymphatic embolization of intractable hepatic lymphorrhea.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Protein-losing enteropathy and the Fontan operation.

              Protein-losing enteropathy (PLE) is a complex disorder characterized by enteric protein loss and often is associated with cardiovascular abnormalities, particularly those with elevated central venous pressure. The Fontan operation is a surgical procedure used to palliate patients with a functional single ventricle. Although the Fontan operation eliminates cyanosis and decreases the workload of the functionally single ventricle, it also elevates central venous pressure. This can result in hepatic and enteric congestion as well as PLE. Despite the universal elevation in central venous pressure, only a fraction of patients who have had a Fontan operation develop PLE. However, PLE is associated with significant morbidity and mortality. Presenting signs and symptoms of PLE include abdominal bloating, diarrhea, edema, pleural effusions, ascites, and failure to thrive. In this review, the authors discuss the diagnosis and prevalence of PLE after the Fontan operation and review currently available therapeutic strategies.
                Bookmark

                Author and article information

                Journal
                Pediatr Gastroenterol Hepatol Nutr
                Pediatr Gastroenterol Hepatol Nutr
                PGHN
                Pediatric Gastroenterology, Hepatology & Nutrition
                The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition
                2234-8646
                2234-8840
                November 2019
                07 November 2019
                : 22
                : 6
                : 594-600
                Affiliations
                [1 ]Department of Pediatrics, The University of Arizona College of Medicine, Tucson, AZ, USA.
                [2 ]Department of Surgery, The University of Arizona College of Medicine, Tucson, AZ, USA.
                [3 ]Center for Lymphatic Imaging and Interventions, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
                Author notes
                Correspondence to Ranjit I Kylat. Department of Pediatrics, University of Arizona College of Medicine, PO Box 245073, 1501 N Campbell Avenue, Tucson, AZ 85724, USA. rkylat@ 123456gmail.com
                Author information
                https://orcid.org/0000-0001-9666-6883
                https://orcid.org/0000-0001-5505-934X
                https://orcid.org/0000-0003-2306-6099
                https://orcid.org/0000-0003-0531-8723
                https://orcid.org/0000-0002-9426-6760
                Article
                10.5223/pghn.2019.22.6.594
                6856498
                31777727
                a5f3adbd-3c00-4422-9dc6-5cdeda1193f4
                Copyright © 2019 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition

                This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 20 September 2018
                : 27 December 2018
                : 01 January 2019
                Categories
                Case Report

                protein-losing enteropathies,embolization, therapeutic,heart defects, congenital,cardiac surgical procedures,lymphatic abnormalities

                Comments

                Comment on this article